MwanzoBNTC • NASDAQ
add
Benitec Biopharma Inc
Bei iliyotangulia
$Â 13.59
Bei za siku
$Â 13.16 - $Â 13.82
Bei za mwaka
$Â 5.74 - $Â 16.90
Thamani ya kampuni katika soko
348.45M USD
Wastani wa hisa zilizouzwa
elfu 57.66
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 8.61M | 24.31% |
Mapato halisi | -7.36M | -8.22% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | — | — |
EBITDA | -8.60M | -24.40% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 78.28M | 284.23% |
Jumla ya mali | 79.07M | 270.29% |
Jumla ya dhima | 3.13M | -46.85% |
Jumla ya hisa | 75.94M | — |
hisa zilizosalia | 23.45M | — |
Uwiano wa bei na thamani | 4.19 | — |
Faida inayotokana na mali | -29.12% | — |
Faida inayotokana mtaji | -30.65% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -7.36M | -8.22% |
Pesa kutokana na shughuli | -7.70M | -43.58% |
Pesa kutokana na uwekezaji | elfu -12.00 | — |
Pesa kutokana na ufadhili | 17.87M | 45,725.64% |
Mabadiliko halisi ya pesa taslimu | 10.44M | 290.20% |
Mtiririko huru wa pesa | -5.70M | -101.38% |
Kuhusu
Benitec Biopharma Limited is an Australian biotechnology company founded in 1997. It is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases using DNA-directed RNA interference technology.
The CSIRO has researched RNAi extensively, developing the small hairpin RNA concept employed in ddRNAi. Benitec Biopharma has an exclusive license to this ddRNAi technology in human therapeutic uses and research. Wikipedia
Ilianzishwa
1997
Tovuti
Wafanyakazi
16
